Ibrutinib monotherapy produces long‐term disease control in previously treated Waldenstrom's macroglobulinemia. Final report of the pivotal trial (NCT01614821) Meeting Abstract
| Authors: | Treon, S. P.; Meid, K.; Gustine, J.; Yang, G.; Xu, L.; Patterson, C. J.; Ghobrial, I.; Laubach, J. P.; Hunter, Z. R.; Dubeau, T.; Palomba, L.; Advani, R.; Castillo, J. J. |
| Abstract Title: | Ibrutinib monotherapy produces long‐term disease control in previously treated Waldenstrom's macroglobulinemia. Final report of the pivotal trial (NCT01614821) |
| Meeting Title: | 15th International Conference on Malignant Lymphoma |
| Journal Title: | Hematological Oncology |
| Volume: | 37 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2019 Jun 18-22 |
| Meeting Location: | Lugano, Switzerland |
| ISSN: | 0278-0232 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2019-06-01 |
| Start Page: | 184 |
| End Page: | 185 |
| Language: | English |
| ACCESSION: | 136932485 |
| DOI: | 10.1002/hon.141_2629 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cin20 |
| PUBMED: | 31187525 |
| DOI/URL: | |
| Notes: | Meeting Abstract: 135 -- Accession Number: 136932485 -- Entry Date: In Process -- Revision Date: 20190617 -- Publication Type: Article -- Supplement Title: Jun2019 Supplement S1 -- Journal Subset: Biomedical; Europe; Peer Reviewed; UK & Ireland -- NLM UID: 8307268. -- Source: cin20 |
